📣 VC round data is live. Check it out!
- Public Comps
- Chemed
Chemed Valuation Multiples
Discover revenue and EBITDA valuation multiples for Chemed and similar public comparables like Hinge Health, Brookdale Senior Living, National Healthcare Corp, Emeis and more.
Chemed Overview
About Chemed
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. Through its subsidiaries, the company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.
Founded
1970
HQ

Employees
15.7K
Website
Sectors
Financials (LTM)
EV
$6B
Valuation Multiples
Start free trialChemed Financials
Chemed reported last 12-month revenue of $3B and EBITDA of $476M.
In the same LTM period, Chemed generated $849M in gross profit, $476M in EBITDA, and $284M in net income.
Revenue (LTM)
Chemed P&L
In the most recent fiscal year, Chemed reported revenue of $3B and EBITDA of $459M.
Chemed is profitable as of last fiscal year, with gross margin of 33%, EBITDA margin of 18%, and net margin of 10%.
Financial data powered by Morningstar, Inc.
Chemed Stock Performance
Chemed has current market cap of $6B, and enterprise value of $6B.
Market Cap Evolution
Chemed's stock price is $422.84.
Chemed share price decreased by 0.8% in the last 30 days, and by 13.2% in the last year.
Chemed has an EPS (earnings per share) of $19.98.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $6B | $6B | -0.8% | -0.8% | 11.9% | -13.2% | $19.98 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialChemed Valuation Multiples
Chemed trades at 2.2x EV/Revenue multiple, and 12.3x EV/EBITDA.
EV / Revenue (LTM)
Chemed Financial Valuation Multiples
As of June 2, 2026, Chemed has market cap of $6B and EV of $6B.
Chemed has a P/E ratio of 19.8x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Chemed Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Chemed Margins & Growth Rates
Chemed grew revenue by 6% and EBITDA by 9% in the last fiscal year.
In the most recent fiscal year, Chemed reported gross margin of 33%, EBITDA margin of 18%, and net margin of 10%.
Chemed Margins
Chemed Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Chemed Operational KPIs
Chemed's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.0M for the same period.
Chemed's Rule of 40 is 25% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Chemed's Rule of X is 35% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Chemed Competitors
Chemed competitors include Hinge Health, Brookdale Senior Living, National Healthcare Corp, Emeis, Extendicare, Attendo, Clariane, Addus HomeCare, Ensign Group and BrightSpring Health.
Most Chemed public comparables operate across Long-Term Care.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 7.8x | 6.8x | 38.0x | 28.6x | |||
| 2.6x | 2.6x | 17.8x | 17.1x | |||
| 1.7x | - | 12.1x | - | |||
| 1.8x | 1.8x | 12.8x | 12.3x | |||
| 1.7x | 1.5x | 15.6x | 13.9x | |||
| 1.6x | 1.7x | 8.1x | 8.1x | |||
| 1.6x | 1.6x | 7.4x | 7.8x | |||
| 1.2x | 1.2x | 9.5x | 9.2x | |||
This data is available for Pro users. Sign up to see all Chemed competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Chemed
| When was Chemed founded? | Chemed was founded in 1970. |
| Where is Chemed headquartered? | Chemed is headquartered in United States. |
| How many employees does Chemed have? | As of today, Chemed has over 15K employees. |
| Who is the CEO of Chemed? | Chemed's CEO is Kevin J. Mcnamara. |
| Is Chemed publicly listed? | Yes, Chemed is a public company listed on NYSE. |
| What is the stock symbol of Chemed? | Chemed trades under CHE ticker. |
| When did Chemed go public? | Chemed went public in 1972. |
| Who are competitors of Chemed? | Chemed main competitors include Hinge Health, Brookdale Senior Living, National Healthcare Corp, Emeis, Extendicare, Attendo, Clariane, Addus HomeCare, Ensign Group, BrightSpring Health. |
| What is the current market cap of Chemed? | Chemed's current market cap is $6B. |
| What is the current revenue of Chemed? | Chemed's last 12 months revenue is $3B. |
| What is the current revenue growth of Chemed? | Chemed revenue growth (NTM/LTM) is 6%. |
| What is the current EV/Revenue multiple of Chemed? | Current revenue multiple of Chemed is 2.2x. |
| What is the current EBITDA of Chemed? | Chemed's last 12 months EBITDA is $476M. |
| What is Chemed's EBITDA margin? | Chemed's last 12 months EBITDA margin is 18%. |
| What is the current EV/EBITDA multiple of Chemed? | Current EBITDA multiple of Chemed is 12.3x. |
| What is the current FCF of Chemed? | Chemed's last 12 months FCF is $323M. |
| What is Chemed's FCF margin? | Chemed's last 12 months FCF margin is 12%. |
| What is the current EV/FCF multiple of Chemed? | Current FCF multiple of Chemed is 18.0x. |
| How many companies Chemed has acquired to date? | Chemed hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Chemed has invested to date? | Chemed hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Chemed
Lists including Chemed
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.